Chemours Co.'s next confirmed earnings release is scheduled for February 11, 2027.
| Earnings Date | 2/11/2027 |
As of June 30, 2026, Chemours Co. has 150.46M shares outstanding.
| Shares Outstanding | 150.46M |
As of June 30, 2026, Chemours Co. maintains a current ratio of 1.66, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -8,583.33, indicating conservative leverage, while an interest coverage ratio of 1.75 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.66 |
| Quick Ratio | 0.85 |
| Debt / Equity | -8,583.33 |
| Debt / EBITDA | 8.62 |
| Interest Coverage | 1.75 |
These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -4.15, reflecting losses generated across the asset base. The company generates approximately 878,634.48 in revenue per employee across its workforce of 5,775.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.26 indicates how many times Chemours Co. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Assets (ROA) | -4.15 |
| Revenue Per Employee | 878,634.48 |
| Employee Count | 5,775.00 |
| Inventory Turnover | 3.26 |
Over the twelve months ended June 30, 2026, Chemours Co. recorded 232.83M in income tax expense. The company reported a pretax loss of -34.14M and -266.09M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | 232.83M |
Over the twelve months ended June 30, 2026, Chemours Co. generated 5.07B in revenue and converted that into -266.09M in net income, yielding earnings per share of -1.76. EBITDA reached 418.39M, while operating income came in at -72.65M.
| Revenue | 5.07B |
| Gross Profit | 776.39M |
| Operating Income | -72.65M |
| Pretax Income | -34.14M |
| Net Income | -266.09M |
| EBITDA | 418.39M |
| EBIT | 139.17M |
| Earnings Per Share (EPS) | -1.76 |
As of June 30, 2026, Chemours Co. holds 587.33M in cash and equivalents against 3.61B in total debt, resulting in a net debt position of 2.80B. Total book value stands at -42.89M, with working capital of 1.08B providing operational flexibility.
| Cash & Cash Equivalents | 587.33M |
| Total Debt | 3.61B |
| Net Debt | 2.80B |
| Equity (Book Value) | -42.89M |
| Book Value Per Share | -0.29 |
| Working Capital | 1.08B |
Chemours Co. produced 347.49M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -156.68M in capital expenditures, free cash flow totaled 190.82M - equivalent to 1.27 per share.
| Operating Cash Flow | 347.49M |
| Capital Expenditures | -156.68M |
| Free Cash Flow | 190.82M |
| FCF Per Share | 1.27 |
Over the twelve months ended June 30, 2026, Chemours Co. posted a gross margin of 15.30, reflecting its pricing power and cost economics. The operating margin of -1.43 and net profit margin of -5.24 provide insight into operational efficiency.
| Gross Margin | 15.30 |
| Operating Margin | -1.43 |
| Pretax Margin | -0.67 |
| Profit Margin | -5.24 |
| EBITDA Margin | 8.25 |
Over the twelve months ended June 30, 2026, Chemours Co. paid dividends of 0.31 per share. The dividend payout ratio of -17.65 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.
| Dividend Per Share | 0.31 |
| Payout Ratio | -17.65 |